BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1657104)

  • 1. Lymphomatoid papulosis, Ki-1+ lymphoma, and primary cutaneous Hodgkin's disease.
    Kadin ME
    Semin Dermatol; 1991 Sep; 10(3):164-71. PubMed ID: 1657104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary and secondary cutaneous Ki-1+ (CD30+) anaplastic large cell lymphomas. Morphologic, immunohistologic, and clinical-characteristics.
    Kaudewitz P; Stein H; Dallenbach F; Eckert F; Bieber K; Burg G; Braun-Falco O
    Am J Pathol; 1989 Aug; 135(2):359-67. PubMed ID: 2551170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone.
    Davis TH; Morton CC; Miller-Cassman R; Balk SP; Kadin ME
    N Engl J Med; 1992 Apr; 326(17):1115-22. PubMed ID: 1532439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lymphomatoid papulosis evolving into malignant lymphoma. Clinico-pathological and immunohistochemical study of 3 cases].
    Bustos de Abajo M; Serrano Ortega S; Medina Cano MT; Aguilar Peña D; Gutiérrez Salmerón MT; Gómez Morales M; García del Moral R
    Med Clin (Barc); 1993 Feb; 100(6):220-2. PubMed ID: 8429728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD30/Ki-1-positive anaplastic large cell lymphoma preceded by Hodgkin's disease.
    Tsurumi H; Takahashi T; Moriwaki H; Muto Y
    Int J Hematol; 1992 Aug; 56(1):99-102. PubMed ID: 1327272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of CD30 (Ki-1/Ber-H2) expression in primary cutaneous large-cell lymphomas of T-cell origin. A clinicopathologic and immunohistochemical study in 20 patients.
    Beljaards RC; Meijer CJ; Scheffer E; Toonstra J; van Vloten WA; van der Putte SC; Geerts ML; Willemze R
    Am J Pathol; 1989 Dec; 135(6):1169-78. PubMed ID: 2556926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of the Hodgkin's disease-associated antigen Ki-1 in cutaneous infiltrates.
    van der Putte SC; Toonstra J; van Wichen DF; van Unnik JA; van Vloten WA
    Acta Derm Venereol; 1988; 68(3):202-8. PubMed ID: 2455412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphomatoid papulosis.
    Willemze R
    Dermatol Clin; 1985 Oct; 3(4):735-47. PubMed ID: 3916178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphomatoid papulosis. A cutaneous proliferation of activated helper T cells expressing Hodgkin's disease-associated antigens.
    Kadin M; Nasu K; Sako D; Said J; Vonderheid E
    Am J Pathol; 1985 May; 119(2):315-25. PubMed ID: 3158209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphomatoid papulosis followed by Hodgkin's lymphoma. Differential response to therapy.
    Zackheim HS; LeBoit PE; Gordon BI; Glassberg AB
    Arch Dermatol; 1993 Jan; 129(1):86-91. PubMed ID: 8420496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Skin involvement in Hodgkin's disease].
    Requena Caballero L; Sánchez López M; Requena Caballero C; Vázquez López F; Hernández Moro B
    Med Cutan Ibero Lat Am; 1988; 16(2):106-10. PubMed ID: 3050325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin's disease followed by lymphomatoid papulosis. Immunophenotypic evidence for a close relationship between lymphomatoid papulosis and Hodgkin's disease.
    Kaudewitz P; Stein H; Plewig G; Schwarting R; Gerdes J; Burg G; Kind P; Eckert F; Braun-Falco O
    J Am Acad Dermatol; 1990 Jun; 22(6 Pt 1):999-1006. PubMed ID: 2370346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous Ki-1 lymphoma: pathology, immunology and clinical characteristics.
    Kadin ME
    Princess Takamatsu Symp; 1987; 18():187-95. PubMed ID: 3506541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphomatoid papulosis and Ki-1 (CD30)-positive cutaneous large cell lymphomas.
    Kaudewitz P; Burg G
    Semin Diagn Pathol; 1991 May; 8(2):117-24. PubMed ID: 1651550
    [No Abstract]   [Full Text] [Related]  

  • 15. Atypical cells in lymphomatoid papulosis express the Hodgkin cell-associated antigen Ki-1.
    Kaudewitz P; Stein H; Burg G; Mason DY; Braun-Falco O
    J Invest Dermatol; 1986 Apr; 86(4):350-4. PubMed ID: 2427610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of Hodgkin's disease and cutaneous B-cell lymphoma in the same patient: a report of two cases.
    Servitje O; Martí RM; Estrach T; Palou J; Gallardo F; Limón A; Romagosa V
    Eur J Dermatol; 2000; 10(1):43-6. PubMed ID: 10694298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphomatoid papulosis type A: clinical, morphologic, and immunophenotypic study.
    Sioutos N; Asvesti C; Sivridis E; Aygerinou G; Tsega A; Zakopoulou N; Zographakis I
    Int J Dermatol; 1997 Jul; 36(7):514-7. PubMed ID: 9268749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis in CD30-positive lymphoproliferative disorders of the skin.
    Greisser J; Doebbeling U; Roos M; Mueller B; Schmid M; Burg G; Kadin ME; Kempf W
    Exp Dermatol; 2005 May; 14(5):380-5. PubMed ID: 15854132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary cutaneous Hodgkin's disease. Unique clinical, morphologic, and immunophenotypic findings.
    Sioutos N; Kerl H; Murphy SB; Kadin ME
    Am J Dermatopathol; 1994 Feb; 16(1):2-8. PubMed ID: 8160926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of thymus and activation regulated chemokine and its receptor CCR4 in nodal and cutaneous anaplastic large-cell lymphomas and Hodgkin's disease.
    Vermeer MH; Dukers DF; ten Berge RL; Bloemena E; Wu L; Vos W; de Vries E; Tensen CP; Meijer CJ; Willemze R
    Mod Pathol; 2002 Aug; 15(8):838-44. PubMed ID: 12181269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.